Simulation as a preoperative planning approach in advanced heart failure patients. A retrospective clinical analysis.

BACKGROUND: Modelling and simulation may become clinically applicable tools for detailed evaluation of the cardiovascular system and clinical decision-making to guide therapeutic intervention. Models based on pressure-volume relationship and zero-dimensional representation of the cardiovascular system may be a suitable choice given their simplicity and versatility. This approach has great potential for application in heart failure where the impact of left ventricular assist devices has played a significant role as a bridge to transplant and more recently as a long-term solution for non eligible candidates.
RESULTS: We sought to investigate the value of simulation in the context of three heart failure patients with a view to predict or guide further management. CARDIOSIM© was the software used for this purpose. The study was based on retrospective analysis of haemodynamic data previously discussed at a multidisciplinary meeting. The outcome of the simulations addressed the value of a more quantitative approach in the clinical decision process.
CONCLUSIONS: Although previous experience, co-morbidities and the risk of potentially fatal complications play a role in clinical decision-making, patient-specific modelling may become a daily approach for selection and optimisation of device-based treatment for heart failure patients. Willingness to adopt this integrated approach may be the key to further progress.

Background

Physiological fluid flow modelling using computational fluid dynamics (CFD) has increased our understanding of complex system interactions with particular reference to problem solving in a clinical environment [1-6]. Functional analysis and assessment of the cardiovascular system through computational modelling based on imaging techniques has certainly received great attention in relation to its diagnostic value and planning approach [7-11].

Mathematical modelling and simulation may become clinically applicable tools for detailed evaluation of the cardiovascular system and clinical decision-making to guide therapeutic intervention [12]. Models based on pressure–volume relationship and lumped-parameter representation of the cardiovascular system may be a suitable choice given their simplicity and versatility [13-19]. Although they provide less detailed predictions of pressure and flow waveforms, these models have shown great flexibility in simulating the haemodynamics of different cardiovascular conditions and therapeutic interventions with the potential to be run in real time on desktop, laptop or mobile devices [12]. The successful clinical application of this approach requires further haemodynamics teaching to the medical community although its importance is still far from being fully appreciated [19-21].

This approach has great potential for application in heart failure where the impact of left ventricular assist devices (LVADs) has played a significant role as a bridge to transplant and more recently as a long-term solution for non eligible candidates. Continuous flow rotary blood pumps are currently the most popular devices because of their smaller size, increased reliability and higher durability compared to pulsatile-flow devices. The trend towards their use is increasing. Mathematical modelling and computer simulation are invaluable tools to investigate the interactions between LVADs and the cardiovascular system [22-24]. CFD simulations for continuous flow LVADs are usually performed under steady flow conditions where the inlet boundary is set to a specific steady velocity profile while the outlet boundary is fixed at a steady pressure. The actual unsteady boundary conditions will be dependent on the flow from the heart and the aortic pressure, which are the result of the interactions between the device and the cardiovascular system [25]. The study of the interaction between LVADs and the whole cardiovascular system with a 3-D CFD model is highly demanding although specific parts of the assisted circulation have been developed with this method [26] but their practical application may be limited at present. A more simplified approach is based on one-dimensional (1-D) or lumped parameter (0-D) models where space dependence is either confined to the axial coordinate (1-D) or addressed by splitting the cardiovascular system in compartments (0-D) [27].

The native ventricular behaviour can be modelled according to the time-varying elastance theory [28-30], which remains a landmark despite its limitations [31] and previous criticism when applied to a mechanically supported left ventricle [32]. Significant elastance changes are observed during circulatory support with a blood displacement pump because of extreme and fast changing loading conditions. Therefore, the relationship between elastance and contractility may be no longer applicable when a second pump is connected to the systemic circulation [32]. Elastance changes are also observed with continuous flow pumps where an increasing pump flow is related to a constant end-systolic volume, a decrease in end-diastolic volume and a maximum left ventricular pressure increase with a gradual increase in the slope (Ees) of the end-systolic pressure–volume relationship (ESPVR) to justify dissociation between contractility and elastance [32]. Although a linear model has been proven sufficiently accurate [33-35] and adequate for realistic simulations of the instantaneous pressure–volume relation [36], recent multi-scale modelling of the cardiovascular system [37] based on previously developed approaches [38-40] has successfully addressed the limitations of the time-varying elastance theory with particular reference to load-dependence of ESPVR. Further modelling techniques can describe a failing cardiovascular system [41] and ventricular interactions [42-44]. To address the shortcomings of the original time-varying elastance theory, a nonlinear time-varying lumped parameter model of the cardiovascular system [45] can be modified to include the inter-ventricular septum and a rotor-dynamic, continuous flow LVAD [46]. This is a more accurate heart failure model where the ESPVR is a unimodal function that takes into account the descending limb of the Frank–Starling curve, making it particularly suitable to study ventricular interactions and the leftward septal shift secondary to left ventricular decompression following LVAD insertion. Outlet tube pump modelling with a linearly flow-dependent resistance is also used to study pulsatile and continuous flow LVADs. The resistance consists of flow-proportional and constant components in the context of a steady state environment but dynamic modelling with a time-varying resistance has been considered more recently [47, 48]. A Lagrange multiplier coupling approach [49] can be applied to LVAD modelling [50] using fictitious domain methods [51, 52] to address the interactions between the LVAD cannula and the ventricle at the expense of significant increase in computational time and instability in specific regions of interface between the fluid and solid meshes. To overcome these limitations, a fluid–solid left ventricular model coupled with a 0-D Windkessel model [53, 54] already successfully applied to different types of LVAD [55-57] can be used where optimization with high order interpolation at the fluid–solid boundary allows simulations of fluid–solid interaction over a complete cardiac cycle during LVAD support [58].

Following these considerations, we sought to investigate the value of simulation in the context of three heart failure patients previously discussed at a multidisciplinary meeting with a view to predict or guide further management. The aim was to compare the outcome of the simulations with the previously made clinical decision in order to find out any relationship that may be applicable on a routine basis in future patient assessment. The key elements would be:

A more targeted approach for different group of patients;

More quantitative evaluation in the clinical decision process;

The predictive value of simulation;

Preoperative planning and treatment optimisation.

Methods

We retrospectively analysed the haemodynamic data of three heart failure patients previously discussed at a multidisciplinary meeting and subsequently treated accordingly. Given the retrospective nature of this study, informed consent was waived [59]. The aim was to reproduce the preoperative haemodynamic status of these patients and then carry out simulations in the presence of a ventricular assist device in order to evaluate their suitability for prolonged mechanical support or other intervention.

The study was carried out using CARDIOSIM©, which is a software package developed by the Cardiovascular Numerical Modelling LAB linked to the Institute of Clinical Physiology, CNR, Rome, Italy [60]. This is a numerical simulator of the cardiovascular system based on lumped parameter models, modified time-varying elastance and pressure–volume analysis of ventricular function. The software is interactive and capable of reproducing physiological and pathological conditions for clinical decision-making in a controlled environment [14, 15]. The main feature is a modular approach with an updatable library of numerical models of different sections of the cardiovascular system, which can be assembled according to the need of the simulation. The software is particularly suitable to study the interactions with pulsatile or continuous flow ventricular assist devices [15, 22–24], intra-aortic balloon pump, artificial lung, biventricular assist device and biventricular pacing [15, 18, 61–63].

When the native atrial and ventricular behaviour are modelled, the numerical simulator allows choosing between two different modules [16-19] based on the time-varying elastance theory. For the purpose of our simulations, we have considered the module where left and right ventricular elastances and are described as a function of the characteristic elastance in systole ( and ) and in diastole ( and ), and an activation function ( and ) as follows [54]:where is the duration of the ECG signal (heart period), is the end of ventricular systole and is the T-wave peak time [15, 19].

Instantaneous left and right ventricular pressures and are obtained from the instantaneous ventricular free wall volumes and elastances as follows [54]:where and are the instantaneous left and right ventricular free wall volumes; and are the resting left and right ventricular volumes; and are the resting left and right ventricular pressures.

The same approach is applicable to the atrial chambers, the interventricular (IVS) and interatrial (IAS) septum [15]. The IVS is the key factor where the properties of one ventricle are a function of the contra-lateral one [64]. When the time-varying elastance theory is applied, from Eq. (1) we obtain [15, 19]:where is the septal ventricular elastance described in [15, 19]. and represent the instantaneous left and right ventricular volume respectively.

Equation (2) are essential for the model to simulate ventricular interactions with or without mechanical circulatory support.

Similarly, the following equations were used to reproduce the atrial behaviour [15, 19]:where is the septal atrial elastance described in [15, 19]; and are the left and right atrial elastances; [] and [] are the instantaneous left and right atrial pressures [volumes]; and are the resting left and right atrial volumes.

Equation (3) are essential for the model to simulate atrial interactions with or without mechanical circulatory support.

The systemic arterial section consists of the aortic, thoracic and abdominal compartment and is modelled as described in [14, 65] with RLC circuits (Fig. 1). The whole venous system is modelled with only one RC circuit. The inertial forces have been neglected. The pulmonary arterial section consists of the main pulmonary artery and the intra-pulmonary vascular bed, each modelled with a RLC lumped element. The pulmonary arteriole compartment consists of a single resistance in view of their relative stiffness and the fact that inertial forces are negligible. The pulmonary capillary section is also modelled with a single resistance as previously reported [18]. Coupling between the ventricles and the circulation is obtained by using ideal valves [17, 22]. The potential for research, clinical application and training is significant and well documented [14, 15, 21, 66].

Fig. 1

Electrical analogue model of the cardiovascular system. The systemic arterial section consists of three RLC elements representing the aortic (RAT, LAT and CAT), thoracic (RTT, LTT and CTT) and abdominal (RABT, LABT and CABT) tract respectively. Ras is the variable systemic peripheral resistance. The systemic venous section consists of two variable resistances (Rvs1 and Rvs2) and a compliance (Cvs). The main (small) pulmonary section is reproduced by a RLC element: Rpam, Lpam and Cpam (Rpas, Lpas and Cpas). The arteriole (capillary) bed behaviour is reproduced by a single resistance Rpar (Rpc). The pulmonary venous section consists of a compliance (Cvp) and a resistance (Rvp). Pt is the mean intrathoracic pressure

Figure 2 shows the electric analogue of the LVAD model (Berlin Heart INCOR Pump) [55] integrated in the software and used for our simulations. The inlet and outlet cannulae are modelled with RLC elements and .

Fig. 2

Electrical analogue model of the Berlin Heart INCOR pump. Plv ad Pas are the left ventricular and systemic arterial pressures respectively. Input (output) pump cannula is modelled with a resistance Rvpi (Rvpo), a compliance Cvpi (Cvpo) and an inertance Lvpi (Lvpo). Qvad is the pump flow and Qvpi (Qvpo) is the input (output) cannula flow

The inlet and outlet cannulae flows and are calculated as follows:where is the mean intrathoracic pressure, is the systemic atrial pressure, and are the inlet and outlet cannulae pressures.

The LVAD flow is described by:where is the component of the LVAD speed; is the amplitude of the pulsation component; is the phase difference between the LVAD pulsation component and the native cardiac timing. The setting parameters are listed in Table 1.

Table 1

Setting parameters of the LVAD used for the simulations

Parameter	Value	Unit
Inlet and outlet cannulae parameters
C_vpi [C_vpo]	0.1 [0.1]	mmHg−1 ml
R_vpi [R_vpo]	0.01 [0.01]	mmHg s/ml
L_vpi [L_vpo]	1.2 × 10−4 [1.2 × 10−4]	mmHg s2/ml
LVAD parameter
K_vad,1	− 3.0361 × 10−3	l/min/rpm
K_vad,2	− 1.23045	l/min/mmHg
K_vad,3	5.78974 × 10−4	l/min/rpm/mmHg
K_vad,4	− 5.8777 × 10−8	l/min/rpm2/mmHg
K_vad,5	− 1.27359 × 10−6	l/min/rpm/mmHg2
K_vad,6	2.04834 × 10−10	l/min/rpm2/mmHg2

The first order ordinary differential equations of the cardiovascular model were initially solved using both Euler’s and fourth order Runge–Kutta’s methods. The two numerical methods gave the same results under steady state conditions. The Euler’s method with a time step of 1 ms was preferred because of its lower computational cost compared to the Runge–Kutta’s method. The simulation software was written using Visual Basic language. Statistical analysis was carried out using the unpaired “t” test and correlation coefficients were calculated.

The retrospective analysis was performed on the haemodynamic data of the following patients:

Patient 1

A 34-year-old patient who sustained an extensive anterior wall myocardial infarction, which was initially treated with a percutaneous interventional procedure and the insertion of a drug eluting stent to the left anterior descending coronary artery. Subsequently, stent occlusion and residual severe left ventricular systolic dysfunction with an ejection fraction of 27% required full anti-failure treatment. Further deterioration required dobutamine infusion and close monitoring. The presence of co-morbidities, particularly high body mass index (BMI), made this patient unsuitable for transplant while the insertion of a left ventricular assist device remained debatable and unlikely to be beneficial. Haemodynamic data from repeated right heart catheter showed persistent elevated pulmonary artery pressures and resistance with significantly reduced right ventricular stroke work index, which increased the need for right ventricular support following LVAD insertion with potential for prolonged intensive care need and increased risk and complications. The final decision following a multidisciplinary team (MDT) meeting was to continue with medical management and palliative treatment. Table 2 shows measured haemodynamic data following right heart catheterisation (RHC) on admission and 4 days later. End-diastolic ventricular volume [EDV = (CO/HR)/EF], end-systolic ventricular volume [ESV = EDV − (CO/HR)] and the slope (Ea) of arterial elastance (Ea ≈ BPmean/SV) [65], where SV is the stroke volume, were estimated from the measured parameters.

Table 2

Measurements following right heart catheterisation on admission (RHC 1) and after 4 days (RHC 2)

Patient #1	RHC 1 (admission)			RHC 2 (after 4 days)
	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	85–90	59	69.3	85–90	60	70
RA (mmHg)	35	17	29	38	22	32
RV (mmHg)	61	14	38	71	11	44
PA (mmHg)	62	30	42	70	38	50
PCWP (mmHg)	36	31	32	35	25	34
TPG (mmHg)	10			16
CO (l/min)	2.7			2.8
CI (l/min/m2)	1.36			1.4
PVR (wood unit)	3.7			5.7
RVSWI (g/m2/beat)	2.4			2.4
HR (bpm)	100			95
BSA (m2)	1.98			1.98
EFLeft (%)	27			27
Estimated values
EDV (ml)	~ 100			~ 109
ESV (ml)	~ 73			~ 80
Ea (mmHg/ml)	~ 3.0			~ 2.8

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance

Patient 2

A 55-year-old patient with hypertrophic cardiomyopathy (NYH7 mutation), who previously underwent aortic valve replacement with a mechanical prosthesis and subsequently percutaneous intervention to the left anterior descending coronary artery. Left ventricular ejection fraction EFLeft was 45% in the context of chronic atrial fibrillation, previous ventricular arrhythmias and renal impairment. Symptoms deterioration required multiple hospital admissions with readjustment of anti-failure treatment and finally commenced on Milrinone (PDE3 inhibitor) infusion. A MDT meeting considered a LVAD not a suitable option and therefore this patient was placed on the transplant list. Table 3 shows measured and estimated haemodynamic data on admission, 1 and 2 months later.

Table 3

Measurements following right heart catheterisation on admission (RHC 1), after 1 month (RHC 2) and after 2 months (RHC 3)

Patient #2	RHC 1 (admission)			RHC 2 (after 1 month)			RHC 3 (after 2 months)
	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	95–100	58	72	–	–	–	–	–	–
RA (mmHg)	14	2	9	10	4	6	11	1	7
RV (mmHg)	39	2	17	37	1	15	32	-2	14
PA (mmHg)	40	17	27	34	15	26	31	14	22
PCWP (mmHg)	28	7	18	26	8	15	26	11	15
TPG (mmHg)	9			11			7
CO (l/min)	5.3			7.1			5.6
CI (l/min/m2)	2.26			3.02			2.4
PVR (wood unit)	1.7			1.55			1.25
RVSWI (g/m2/beat)	8.5			9.35			6.2
HR (bpm)	65			88			78
BSA (m2)	2.35			2.35			2.35
EFLeft (%)	45			–			–
Estimated values
EDV (ml)	~ 181			–			–
ESV (ml)	~ 99			–			–
Ea (mmHg/ml)	~ 1.1			–			–

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance

Patient 3

A 52-year-old patient who previously sustained a myocardial infarction requiring coronary artery bypass grafting and subsequently implantable cardioverter defibrillator (ICD) insertion because of ventricular arrhythmias. Significant deterioration of the clinical picture had already required multiple hospital admission in a background of dilated left ventricle (left ventricular end-diastolic diameter 8.1 cm) with severe systolic (left ventricular ejection fraction 15%) and diastolic dysfunction (E/A ratio 3.4) and severe pulmonary hypertension. Finally, Milrinone and diuretic infusion were commenced and an intra-aortic balloon pump was inserted. Following a MDT meeting, this patient was listed for transplant with a view to LVAD insertion if further deterioration occurred. Table 4 shows measured and estimated haemodynamic data on admission, 15 and 22 days later.

Table 4

Measurements following right heart catheterisation on admission (RHC 1), after 15 days (RHC 2) and after 22 days (RHC 3)

Patient #3	RHC 1 (admission)			RHC 2 (after 15 days)			RHC 3 (after 22 days)
	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	100	60	73.3	–	–	–	–	–	–
RA (mmHg)	14	12	9	18	11	15	14	6	10
RV (mmHg)	53	5	–	60	4	28	67	-3	28
PA (mmHg)	58	27	37	75	33	44	75	36	48
PCWP (mmHg)	39	29	31	48	26	35	47	26	33
TPG (mmHg)	6			9			15
CO (l/min)	4.2			4.5			2.6
CI (l/min/m2)	1.94			2.1			1.2
PVR (wood unit)	1.4			2			6.8
RVSWI (g/m2/beat)	9.87			11.4			9.15
HR (bpm)	75			72			68
BSA (m2)	2.16			2.16			2.16
EFLeft (%)	15			–			–
Estimated values
EDV (ml)	~ 373			–			–
ESV (ml)	~ 317			–			–
Ea (mmHg/ml)	~ 1.6			–			–

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance

The diseased status for each patient was reproduced starting from the measured parameters. Subsequently, LVAD support without and with drug administration (Milrinone) was applied to each patient. The effects induced by Milrinone administration were simulated with the aim to increase heart contractility by 10% and reduce pulmonary and systemic resistances by 10%.

Results

Table 5 shows (for the first patient) the comparison between measured (second column) and simulated parameters (third column) for “Admission” conditions. In simulated conditions, the simulator calculates the slope Ees of the end-systolic pressure–volume relationships (ESPVR) and the ratio Ea/Ees. In normal conditions, Ea/Ees ratio represents a reliable index of ventricular–arterial coupling. The estimated and simulated Ea are similar. The last column of the table shows simulated values during LVAD assistance. EDV, ESV and SV decreased with a leftward shift of the left ventricular loop (in the pressure–volume plane) during LVAD support. Moreover, Ea decreased from 3.2 (mmHg/ml) to 2.6 (mmHg/ml) and the Ea/Ees ratio decreased from 3.64 to 2.95 during assistance. Two different values for PVR are reported in Table 5: the first one is calculated as the ratio between TPG and left ventricular output flow (COVENTR), the second one is calculated as the ratio between TPG and LVAD flow (QVAD).

Table 5

Comparison between measured and simulated parameters for patient 1 on admission

Patient #1	Measured (RHC 1)			Simulation (RHC 1)			LVAD (simulation)
	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	85–90	59	69.3	87.2	60.7	69.3	75.2	62.9	68.2
RA (mmHg)	35	17	29	10.5	3.5	6.5	10.3	3.5	6.5
RV (mmHg)	61	14	38	44.2	8.0	20.4	43.5	8.0	20.1
PA (mmHg)	62.0	30.0	42.0	44.0	39.7	42.0	43.3	38.7	40.9
PCWP (mmHg)	36.0	21.0	32.0	31	18.7	25.0	29.6	16.8	23.1
HR (bpm)	100			100			100
EFLeft (%)	27			26.9			31.4
BSA (m2)	1.98			1.98			1.98
CO (l/min)	2.7			2.7			COVENTR 0.67
							QVAD 2.15
							TOT 2.82
CI (l/min/m2)	1.36			1.36			0.34
TPG (mmHg)	10			17			18
PVR (wood unit)	3.7			6.3			26.87 (18.0/0.67)
							6.38 (18.0/2.15)
RVSWI (g/m2/beat)	2.4			6.53			6.86

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance, Ees slope of end-systolic pressure–volume relationship (ESPVR)

Table 6 shows (for the second patient) the comparison between measured (second column) and simulated parameter (third column) for “Admission” conditions. The third and fourth columns represent two different simulated assisted conditions. The first one is obtained applying LVAD support, the second is obtained applying LVAD support and considering the effects induced by Milrinone. Figure 3 shows a screen output produced by our simulator when LVAD support was applied on the simulated “Admission” condition. In the left ventricular pressure–volume plane, the upper window shows the ventricular loop in “Admission” conditions (loop A) and the ventricular loop obtained when LVAD support was applied (loop B). In addition, Fig. 3 shows that the arterial elastance changes as reported in Table 6 where the Ea/Ees ratio decreases from 1.62 to 1.32 when LVAD support is applied. When the effects induced by the simultaneous presence of LVAD and pharmacological treatment are simulated, left ventricular ejection fraction EFLeft increases from 45.1% (“Admission” conditions) to 55.9% and the Ea/Ees ratio decreases from 1.62 (“Admission” conditions) to 1.20. LVAD assistance and Milrinone administration reduce EDV and ESV (Table 6). EDV and ESV reduction induced by LVAD support only is shown in Fig. 3 where a leftward shift of the left ventricular loop is observed.

Table 6

Comparison between measured and simulated parameters for patient 2 on admission

Patient #2	Measured (RHC 1)			Simulation (RHC 1)			LVAD (simulation)			LVAD + Mil. (10%) (simulation)
	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	95–100	58	72	97.2	60.5	72	81.7	63.3	70.6	82.2	62.6	70.5
RA (mmHg)	14.0	2.0	9.0	14.9	5.4	10.0	14.9	5.5	10.0	15.2	5.3	10.1
RV (mmHg)	39.0	2.0	17.0	33.5	5.0	14.8	33.6	5.4	15.9	33.4	3.7	14.9
PA (mmHg)	40.0	17.0	27.0	33.0	14.4	23.2	32.2	13.3	22.5	32.9	12.7	22.6
PCWP (mmHg)	28.0	7.0	18.0	26.6	8.9	14.3	25.9	7.9	13.4	27.3	7.6	13.6
HR (bpm)	65			65			65			65
EFLeft (%)	45			45.1			49.8			55.9
BSA (m2)	2.35			2.35			2.35			2.35
CO (l/min)	5.3			5.3			COVENTR 1.72			COVENTR 2.04
							QVAD 3.67			QVAD 3.92
							TOT 5.39			TOT 5.96
CI (l/min/m2)	2.26			2.26			0.73			0.82
TPG (mmHg)	9			8.9			9.1			9.0
PVR (wood unit)	1.7			1.68			5.3 (9.1/1.72)			4.41 (9.0/2.04)
							2.48 (9.1/3.67)			2.30 (9.0/3.92)
RVSWI (g/m2/beat)	8.5			6.23			6.0			6.63

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance, Ees slope of end-systolic pressure–volume relationship (ESPVR)

Fig. 3

Screen output obtained using our simulator. The first step consists of simulating the “Admission” conditions of the second patient. Subsequently, LVAD assistance is applied. The upper window shows the simulated starting ventricular loop (A) and the ventricular loop obtained during LVAD assistance (B) in the left ventricular pressure–volume plane. The mean values (calculated during the cardiac cycle in the presence of LVAD assistance) of pressure, flow and HR are reported in the right column. Mean systolic and diastolic values are reported for the systemic arterial pressure (Pas ≡ BP). Pla is the mean left atrial pressure (Pla ≡ PCWP). Pra is the mean right atrial pressure. Mean pulmonary arterial pressure (Ppam ≡ PA), systemic venous pressure (Pvs) and pulmonary venous pressure (Pvp) are also shown. In the bottom column, mean left/right atrial input flow (Qlia/Qria), left/right ventricular input flow (Qli/Qri) and right ventricular output flow (Qro) assume the same value. The sum of the mean left ventricular output flow (Qlo) and the Qvad (LVAD flow) equals the flow into the circulatory network (Qlo + Qvad = Qlia = Qria = Qro = Qri = Qli). Finally, the left lower box reports the end-systolic volume (Ves ≡ ESV), the end-diastolic volume (Ved ≡ EDV), the stroke volume (SV) and the ejection fraction (EF) for both ventricles

Finally, Table 7 shows the simulation results of the third patient. Again, the Ea/Ees ratio decreased when LVAD support and Milrinone administration were simultaneously applied. Table 7 shows that LVAD support produces a leftward shift of the left ventricular loop in the pressure–volume plane reducing EDV and ESV.

Table 7

Comparison between measured and simulated parameters for patient 3 on admission

Patient #3	Measured (RHC 1)			Simulation (RHC 1)			LVAD (simulation)			LVAD + Mil. (10%) (simulation)
	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean	Max	Min	Mean
BP (mmHg)	100	60	73.3	106.7	60	73.4	82.8	66.6	74.1	85.2	67.4	74.6
RA (mmHg)	14	12	9.0	8.8	1.7	4.4	9.0	1.7	4.6	9.2	0.5	4.6
RV (mmHg)	53	5.0	–	33.0	1.0	11.6	31.5	1.0	11.3	32.4	0.5	11.6
PA (mmHg)	58.0	27.0	37.0	32.8	22.6	28.0	31.3	20.4	26.2	32.2	19.9	26.5
PCWP (mmHg)	39.0	29.0	31.0	28.4	12.3	18.0	26.8	9.5	15.4	28.0	8.9	15.5
HR (bpm)	75			75			75			75
EFLeft (%)	15			15			18.9			21.9
BSA (m2)	2.16			2.16			2.16			2.16
CO (l/min)	4.2			4.2			COVENTR 0.74			COVENTR 0.93
							QVAD 3.8			QVAD 4.22
							TOT 4.54			TOT 5.15
CI (l/min/m2)	1.94			1.94			0.34			0.43
TPG (mmHg)	6			10.0			10.8			11
PVR (wood unit)	1.43			2.38			14.6 (10.8/0.74)			11.83 (11/0.93)
							2.84 (10.8/3.8)			2.61 (11/4.22)
RVSWI (g/m2/beat)	9.87			8.32			8.23			9.47

BP blood pressure, RA right atrial pressure, RV right ventricular pressure, PA pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, TPG trans-pulmonary pressure gradient, CO cardiac output, CI cardiac index, PVR pulmonary vascular resistance, RVSWI right ventricular stroke work index, HR heart rate, BSA body surface area, EF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, Ea arterial elastance, Ees slope of end-systolic pressure–volume relationship (ESPVR)

Discussion

Cardiovascular modelling has been very successful in increasing our knowledge of physiological mechanisms where simplified representations of complex biological systems can be used to study their behaviour at different levels [67]. The Cardiac Physiome project is currently the most ambitious and successful application of mathematical and computational modelling aimed to advance our understanding of physiology using a quantitative multi-scale approach [67, 68]. Cardiovascular modelling has now reached the stage where clinical application in the form of patient-specific modelling may become a daily routine in a non distant future. For this approach to become reality, a model must be reliable, reproducible and reduce uncertainty [67, 68]. While effective in the laboratory, almost all the decision support tools have failed when applied to clinical practice [69]. Therefore, it is essential to overcome skepticism by developing a strong, realistic model that can fulfil the expectations. Our approach is focused on modelling and simulation not as a substitute for clinical experience but as an additional tool to guide therapeutic intervention or predict clinical outcome: the clinician will be the ultimate decision maker. The development of a comprehensive, integrated model of the cardiovascular system based on lumped-parameter models, modified time-varying elastance and pressure–volume analysis of ventricular function is an attractive prospect with a view to clinical application. The differential equations describing such a model can be solved relatively easy and yield answers in terms of pressure–volume loops and time-dependent tracings of pressure, flow and volume that may well help the decision process and management in the clinical setting. CARDIOSIM© fulfils these requirements although we acknowledge that other software such as CircAdapt Simulator, HemoLab and Harvi may be potentially suitable for clinical application. The CircAdapt Simulator is based on the CircAdapt model [70-72], which has been designed to simulate the dynamics of the heart and the circulation with the inclusion of a realistic relationship between pressure–volume load and tissue mechanics where the geometry of the components is obtained by adaptation to mechanical load. The implementation of the TriSeg model [73] enables realistic simulation of ventricular mechanics including interactions between left and right ventricle, dynamics of septal geometry and myofibre mechanics in the three ventricular walls. The interesting feature of the CircAdapt model is its combined adaptation of heart and vessels over a relatively long period of time resulting in self-structuring of the circulation as a system where a steady-state solution is obtained [74, 75]. This feature makes the model a potential tool for clinical application with the aim of predicting the evolution of a diseased status and the effects of an interventional procedure [67, 71, 72, 76, 77] but there is a lack of suitable models for VADs support. Despite its limitations, the CircAdapt model is considered easy to use, requires relatively low computational time and allows realistic simulations of the circulation with boundary conditions suitable for more complicated models based on finite element analysis. HeMoLab (Haemodynamics Modelling Laboratory) is an integrated computational environment for the modelling of the cardiovascular system. It is an effective research tool and a virtual simulation laboratory [78-80]. HeMoLab consists of a combination of models, which can be coupled locally and globally in order to obtain the systemic response of the cardiovascular system: the so called 3-D, 1-D and 0-D models. The propagation of the arterial pulse is represented with a 1-D and 0-D model, which describes the behaviour of the flow rate, mean pressure and cross-sectional area as a function of time. HeMoLab is a suitable environment for the simulation of the effects of aging, vasodilatation, vasoconstriction, rest and exercise and calculation of characteristic impedance of the arterial network. Although attractive, the software remains confined to a research environment at present. Harvi is an interactive simulation textbook of cardiovascular physiology and haemodynamics based on a previously described electrical circuit [81-83] where ventricular and atrial contraction are represented by a modified time-varying elastance approach [12].

A simulation-based approach as a potential preoperative strategy in the context of patient-specific modelling in advanced heart failure may be an additional tool to obtain accurate predictions of device performance in a clinical setting with treatment optimisation of this complex and challenging group of patients [21]. Patients in advanced heart failure are critical and their management can be very demanding with emotion running high when dealing with younger patients. Patient 1 is a typical example of difficult case experienced by one of the authors (MC). Co-morbidities do play a role and must be taken into account during the multidisciplinary team meeting. The clinical cases considered are typical heart failure patients referred for assessment for transplant or LVAD insertion. The outcome of the simulations is quite stimulating and open to debate.

The simulation outcome for patient 1 does show a leftward shift of the pressure–volume loops for the left and right ventricles with adequate ventricular volumes, although the gain in ejection fraction may be initially limited. On the contrary, it is true that further improvement is observed over a period of time [84] making LVAD insertion a suitable option for this patient. Because of the potential complications related to the associated co-morbidities, the unanimous clinical decision to decline any further intervention but continue with medical treatment and eventually palliation may have been the way forward although further argument in favour of LVAD insertion would be the recent evidence supporting the “obesity paradox” in cardiac surgery [85], which is currently the subject of a hot debate.

Simulation of the baseline haemodynamic status for patient 2 shows comparable mean values with those measured during right heart catheter. VAD support shows improved left ventricular ejection fraction with some reduction in pulmonary artery pressures. The outcome for patient 3 is most beneficial with significant reduction of pulmonary artery pressures confirming the primary indication for VAD support to achieve pulmonary haemodynamics compatible with transplantation.

In view of its features, CARDIOSIM© may be a more suitable choice with particular reference to the effects of mechanical circulatory support on the cardiovascular system. Lumped-parameter models assume a uniform distribution of pressure, volume and flow within any specific compartment at any instant in time while higher dimensional models recognise the variation in space of these parameters. Lumped-parameter models consist of simultaneous ordinary differential equations complemented by an algebraic balance equation and are suitable for examination of global distribution of pressure, flow and volume over a range of physiological conditions with inclusion of the interaction between modelled components. Higher dimensional models consist of partial differential equations complemented by balance equations. 1-D models represent wave transmission effects within the vascular system but 3-D numerical solutions are required for complex flow patterns with analytical solutions obtained only for the simplest geometry [86]. A single-branch multiple compartment model of the vascular system is suitable for the evaluation of short-term VAD support compared to an overly detailed vessel branch model where parameter setting becomes quite difficult. Higher level lumped-parameter modelling is required to address the interaction between the circulation and other systems but a compromise between complexity and ability to set the required parameters is needed to personalise an integrated lumped model for a patient-specific approach.

CARDIOSIM© does address the systems interaction with its modular approach and assembly of models with varying degree of complexity although 0-D and 1-D coupling may be required for the evaluation of long-term VAD support.

During our simulations, we have also considered the effect on ventricular–arterial coupling following LVAD support. Age-related vascular stiffening and the concomitant changes in left ventricular diastolic compliance are frequently observed in heart failure with preserved ejection fraction and in aortic valve stenosis [87]. Ventricular–arterial coupling is strictly related to cardiovascular performance and can be accurately quantified in terms of pressure and volume. The left ventricle and the arterial system are considered elastic chambers with known volume elastances where left ventricular performance is measured by Ees, which is the slope of the ESPVR while the arterial system is measured by its elastance Ea, which is the slope of the arterial end-systolic pressure–stroke volume–effective arterial elastance relationship [65, 87]. The Ea/Ees ratio may be considered as a reliable performance index for ventricular–arterial coupling. An Ea/Ees ratio close to 1 relates to appropriate coupling between the left ventricle and the arterial system. Impaired coupling occurs in heart failure where Ees decreases following left ventricular systolic dysfunction and Ea is increased because of elevated impedance and reduced compliance [87]. Our simulations show that LVAD assistance can achieve appropriate ventricular–arterial coupling with an Ea/Ees ratio close to 1. The potential of this parameter may well justify further study for its routine clinical application in heart failure patients.

In summary, a simulation setting may well add a more quantitative approach to help the whole process, generate more critical thinking and perhaps give reassurance. The clinical scenarios discussed in this article are only an example of how the subject can be further developed and used as part of a preoperative planning strategy. Further work is currently being undertaken by our group and the outcome is awaited.

Conclusion

Although previous experience, co-morbidities and the risk of potentially fatal complications play a role in the clinical decision process, a simulation setting may well add a more quantitative approach and perhaps reassurance even if the clinician remains the ultimate decision-maker. Interactive software like CARDIOSIM© can reproduce physiological and pathological conditions for clinical decision-making in a controlled environment. Its modular approach and versatility combined with the high availability of physiological and pathological set up make it suitable for clinical application with particular reference to the evaluation of the effects of interventional procedures on the cardiovascular system such as the interactions with pulsatile and continuous flow VADs and the intra-aortic balloon pump (IABP).

The development of an integrated model of the cardiovascular system based on lumped-parameter representation, modified time-varying elastance and pressure–volume analysis of ventricular function seems a feasible and suitable approach yielding a sufficiently accurate quantitative analysis in real time. The challenge remains the ability to predict outcome over a longer period of time.

Patient-specific modelling may become a daily approach for clinical management and optimisation of device treatment. Willingness to adopt such an integrated approach may be the key to further progress.